Pathophysiology of cardiovascular disease in hemodialysis patients

Kidney International, Supplement

Volumn 58, Issue 76, 2000, Pages

  Meeus, F ^a   Kourilsky, O ^a   Guerin, A P ^a   Gaudry, C ^a   Marchais, S J ^a   London, G M ^a  

^a Hopital Manhes   (France)

Author keywords

Arterial disease; Dialysis mortality; Heart failure; Intensive care; Left ventricular hypertrophy

Indexed keywords

ADULT; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART STRESS; HEMODIALYSIS; HEMODYNAMICS; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; UREMIA; CHRONIC KIDNEY FAILURE; RENAL REPLACEMENT THERAPY; REVIEW;

HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 0033861647     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07618.x     Document Type: Article

References (81)

1. Report on management of renal failure in Europe, XXII, 1991
2. Dialysis ischemic heart disease: Insight from coronary angiography
3. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
4. Outcome and risk factors of ischemic heart disease in chronic uremia
5. Risk factors for the development of left ventricular hypertrophy in a prospective followed cohort of dialysis patients
6. Cardiac disease in chronic uremia: Pathogenesis
7. Impact of left ventricular hypertrophy on survival in end-stage renal disease
8. Disabling angina pectoris with normal coronary arteries in patients undergoing hemodialysis
9. Cardiac and arterial interactions in end-stage renal disease
10. Studies of the vessel wall properties in hemodialysis patients
11. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia
12. Atherosclerosis and arteriosclerosis in chronic renal failure
13. Cardiac hypertrophy: Useful adaptation or pathological process?
14. Cardiomyopathy of overload: A major determinant of prognosis in congestive heart failure
15. Cardiac hypertrophy: Mechanical, neural, and endocrine dependence
16. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes
17. Clinical and echocardiographic disease in patients starting ESRD therapy
18. Pressure-overload cardiomyopathy in end-stage renal disease
19. The role of parathyroid hormone in the genesis of interstitial cell activation in uremia
20. Cardiac remodelling in experimental renal failure - An immunohistochemical study
21. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: Comparative effects of ACE inhibition and calcium channel blockade
22. Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients
23. Endothelin and cardiovascular remodelling in end-stage renal disease
24. Diffuse intramyocardial fibrosis in uraemic patients
25. Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uremia: Evidence for a permissive action of PTH
26. Myocyte/capillary mismatch in the heart of uremic patients
27. The cardiomyopathy of overload: An unnatural growth response in the hypertrophied heart
28. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy
29. Effect of hyperparathyroidism on cardiac function in patients with end-stage renal disease
30. Long-term effects of parathyroidectomy on cardiac and autonomic nervous system functions in haemodialysis patients
31. Parathyroid hormone and cardiac performance in dialysis patients
32. Chronic ET(A) receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats
33. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease
34. Postischemic vasodilation, endothelial activation and cardiovascular remodeling in end-stage renal disease
35. Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine
36. Albumin is an important vascular tonus regulator as a reservoir of nitric oxide
37. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease
38. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
39. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin
40. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uremic patients
41. Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin
42. Relationship between left ventricular hypertrophy, myocardial contractility, and load conditions in hemodialysis patients: An echocardiographic study
43. Hypertension and the arterial system: Clinical and therapeutic aspects
44. Wave reflexion in the systemic circulation and its implications in ventricular function
45. Coronary circulation in dogs with an experimental decrease in aortic compliance
46. Wave reflections and cardiac hypertrophy in chronic uremia: Influence of body size
47. Accelerated atherosclerosis in prolonged maintenance hemodialysis
48. The role of hypertension in hemodialysis-associated atherosclerosis
49. Increased stiffness of radial artery wall material in end-stage renal disease
50. Aortic and large artery compliance in end-stage renal disease
51. Remodelling of radial artery and chronic increase in shear stress
52. Effect of nifedipine administration on pulse wave velocity (PWV) of chronic hemodialysis patients: 2 year trial
53. Increased systolic pressure in chronic uremia: Role of arterial wave reflections
54. Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension
55. Changes of vascular architecture independent of blood pressure in experimental uremia
56. Arterial calcification and pathology in uremic patients undergoing dialysis
57. Endothelium-dependent mechanical properties of carotid artery in WKY and SHR: Role of angiotensin converting enzyme inhibition
58. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis
59. Increased cardiovascular risk factors and features of endothelial dysfunction in dialyzed uremic patients
60. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients
61. Association between plasma homocysteine concentration and extracranial carotid-artery stenosis
62. Plasma homocysteine, aortic stiffness and renal function in hypertensive patients
63. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
64. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study
65. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease
66. Atherosclerosis in uremia: Possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation
67. Relation between carotid artery atherosclerosis and time on dialysis: A non-invasive study in vivo
68. Effect of hyperparathyroidism on arterial distensibility in renal transplant recipients
69. Hypertension in the ESRD patients: Pathophysiology, therapy, outcomes, and future directions
70. Pulse pressure: A predictor of long-term cardiovascular mortality in a French male population
71. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function
72. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study
73. Impact of aortic stiffness on survival in end-stage renal disease
74. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease
75. Arterial compliance in uremia
76. Regression of radial artery wall hypertrophy and improvement of carotid compliance after long-term antihypertensive treatment in elderly patients
77. Salt and water retention and calcium blockade in uremia
78. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition